Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2605541 vs Insulin Glargine in insulin-naive type 2 diabetes
NCT01435616Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2011
- Primary completion
- Jan 2014
- Countries
- 23
01
Overview
A Phase 3 trial of insulin peglispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Nov 2011; status: completed.
02
Drugs
insulin peglispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01435616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435616.